Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat
- 1 July 1985
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 330 (1), 42-49
- https://doi.org/10.1007/bf00586708
Abstract
Comparative pharmacokinetic studies with the β-receptor blocking drugs propranolol, metoprolol, sotalol and atenolol, differing greatly in lipophilicity, and their main route of elimination were performed in light-dark-synchronized rats after equimolar single (6 μmoles/kg) or multiple (6x6 μmoles/kg) drug application. Drug concentrations were determined in plasma and various target organs of the drugs, e.g. heart, muscle, lung and brain, after drug application in the light period (L) and dark period (D), respectively. After single drug administration pharmacokinetic parameters of all drugs depended on the L and D conditions. Elimination half-lives in plasma and organs were shorter during D than during L. No L-D-differences were found in initial drug concentrations of the hydrophilic drugs sotalol and atenolol. In contrast, C0-values of the lipophilic propranolol in highly perfused organs (muscle, lung, brain) and of metoprolol in muscle tissue were significantly higher in D than in L. No obvious temporal dependency was found in other pharmacokinetic parameters (AUC, plasma clearance,Vdβ) with the exception inVdβ of propranolol. Due to the different physico-chemical properties of the compounds inter-drug-differences in pharmacokinetic parameters including drug accumulation into lung and brain tissue were observed. Multiple drug dosing abolished the circadian-phase-dependency in the elimination half-lives of the drugs due to an increase in D. Only for the highly lipophilic propranolol half-lives in highly perfused organs were still shorter in D than in L. It is concluded that L-D-differences in drug half-lives after single dose application are mainly due to circadian variations in drug elimination with a higher hepatic (propranolol, metoprolol) or renal (sotalol, atenolol) elimination in the activity period of rats during D. Additional studies with propranolol on heart rate of conscious rats revealed that a maximum in β-receptor blockade was achieved at 10 μmoles/kg in L but not in D. Thus, it is assumed that abolition of circadian-phase-dependency in half-lives after 6x6 μmoles/kg of the drugs may be due to the longer lasting and more pronounced β-receptor blockade after multiple drug dosing over a period of several hours in D. Thereby, liver-flow-dependent elimination of propranolol and metoprolol and renal elimination of sotalol and atenolol is reduced to base-line levels found in L.Keywords
This publication has 40 references indexed in Scilit:
- Circadian-Phase-Dependency in [3H]-Dihydroalprenolol Binding to Rat Heart Ventricular MembranesChronobiology International, 1984
- Circadian organization of thirteen liver and six brain enzymes of the mouseJournal of Anatomy, 1981
- Etude des variations nycthémérales de la filtration glomérulaire chez le ratCellular and Molecular Life Sciences, 1979
- Circadian rhythm in cerebral blood volume of mouseCellular and Molecular Life Sciences, 1973
- Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primateAmerican Heart Journal, 1973
- The Disposition of PropranololPharmacology, 1972
- Diurnal rhythms in urinary electrolyte excretions by the rat: influence of feeding habitsLife Sciences, 1970
- The influence of light on daily rhythm in hepatic drug metabolizing enzymes in ratLife Sciences, 1969
- Circadian rhythm in hepatic drug metabolizing activity in the ratLife Sciences, 1967
- Über einen 24‐Stunden‐Rhythmus im Blutkreislauf des MenschenActa Medica Scandinavica, 1940